Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000915562 | SCV001060774 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000915562 | SCV001786075 | likely benign | not provided | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002258042 | SCV002531607 | likely benign | Xeroderma pigmentosum | 2021-05-10 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002363367 | SCV002666122 | likely benign | Inborn genetic diseases | 2022-02-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000915562 | SCV004139749 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | ERCC2: BP4, BP7, BS2 |
Genome Diagnostics Laboratory, |
RCV001579378 | SCV001807009 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000915562 | SCV001969596 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004533514 | SCV004736709 | benign | ERCC2-related disorder | 2019-06-18 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |